Skip to main content
Premium Trial:

Request an Annual Quote

DeCode s Q4 Revenues Drop, Losses Narrow Slightly

NEW YORK, Feb. 17 (GenomeWeb News) - DeCode Genetics reported lower revenues year-over-year for the fourth quarter of 2003 today, along with a drop in R&D spending and a decrease in net losses.

DeCode reported revenues of $11.7 million for the quarter, compared to $17.4 million for the same period in 2002. The company attributed the drop-off in revenues to the termination of its contract with Applied Biosystems, which expired in 2002 and contributed $6.3 million to its 2002 fourth-quarter revenues.

The company's fourth-quarter R&D expenses declined to $16.1 million from $20.0 million for the same period in 2002.

DeCode's net loss narrowed slightly for the fourth quarter of 2003, to $10.6 million from $10.9 million in the year-ago period.

At the close of 2003, DeCode had $74.7 million in cash and cash equivalents, including $6 million in restricted cash, compared to $93.2 million in cash and cash equivalents at the end of 2002.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.